The Sage Group, Oriundo and BioStarting Announce Strategic Partnership Focused on Latin America
Date: 19 May 2012
The Sage Group and Oriundo Announce Strategic Partnership Focused on Latin America
Cambridge UK, Clinton, NJ, Mexico City, and Buenos Aires – May 2012 – The Sage Group and Oriundo (www.oriundo.biz), are pleased to announce they have formed a strategic alliance. This alliance will bring a breadth of additional experience and contacts in the healthcare and life science industry and financial sectors in Latin America to Sage clients worldwide. Latin America accounts for about 10% of the global pharmaceutical market. In turn, the alliance will bring Sage’s global experience and contact base to Oriundo’s clients in Latin America.
The Sage Group (www.sagehealthcare.com) is based in USA, Europe, Israel, Australia and Japan. Sage has specialized for nearly 20 years in strategic transactional consultancy for the pharma, biotech, medtech and diagnostics industries. Sage is focused on M&A and licensing transactions for its clients and the 9 Sage principals, based around the world, have completed more than 300 deals, with a total transaction volume in excess of US$5Bn.
Oriundo (www.oriundo.biz) is a network of highly experienced professionals offering consultancy to the pharmaceutical and above all its Business Development community for companies seeking to access Latin America, or indeed companies within Latin America seeking International partners.
Global Pharma companies based in Europe, the USA, Japan and elsewhere have often made heavy weather in Latin America by choosing the wrong partner or entry strategy, or simply turned their back on the fastest growing region, with sales close on U$50bn in 2012, and mainly in the private sector. Both Brazil and Mexico are in the top ten global markets: Brazil at rank # 5 and Mexico #10. Private sector growth stands around 10% CAGR for the last decade.
“We are very pleased to announce this 3-way alliance which will have wide ranging advantages for our global client base” said Wayne Pambianchi, Executive Director of The Sage Group. “Oriundo's strong healthcare and life science industry backgrounds and focus on Latin America will bring a strong new dimension to the services we provide our clients, and will assist in the value creation process that Sage brings to all of our clients.”
“We are delighted to be working with The Sage Group. They will be able to enhance significantly our ability to serve our Latin American clients’ business development needs on a global basis,” said Paul Doulton, Managing Partner of Oriundo.
Oriundo knows its way around the region, and saves risk, time and expense for new entrants. With a strong network of local experts, and clients, throughout Latin America, the Principals have a history of pharmaceutical management at very senior levels with multinationals and nationals. Enforcing the need for full coverage, Oriundo has offices in the major Latin American markets, Brazil, Argentina, Colombia, Mexico, and shortly opening in Peru and Chile, vital to construct a regionwide strategy. Such constructs include make things work through alliances, portfolio enhancement, franchise building, partnering: above all facilitating market entry throughout Latin America’s 20 diverse markets.
Oriundo assists both in finding partners amongst companies already operating in Latin America, as well as establishing sensible market entry routes for companies abroad, involving low investment, whether this be in manufacturing, marketing and sales, regulatory, clinical, market research and the like -- a turnkey solution without the prohibitive price tag.
About The Sage Group, Inc.
The Sage Group Inc. is a leader in the provision of strategic and transactional advice to health care companies in the pharmaceutical, diagnostics, medical device, biotechnology and life science fields. Sage currently maintains offices in USA, Europe, Israel, Australia and Japan. Since its founding in 1994, The Sage Group has served more than 200 clients in the US, Europe and Asia, and completed numerous transactions including divestitures, alliances, acquisitions and financings with values ranging from $5 million to $500 million.
The Sage Group is an organization of experienced and successful executives who are committed to the service of the very vital and dynamic health care industry and its investors.
The range of services offered includes:
Strategic alliances and licensing/partnering
M&A, divestment, buy- and sell- side
Global product and technology acquisition searches
Strategic assessment and planning
Due diligence, technology and molecule assessment, valuation
New ventures, interim management
Facilitating investment in R&D and/or company equity through introductions, network and brokering
The Sage Group's Principals, each an Executive Director, have been Founders, Chairmen, Presidents, CEO's and COO's of a number of emerging health care companies. These Principals have also held senior level management positions in large multi-national organizations. In addition to their management backgrounds, The Sage Group's Principals also have extensive experience in providing professional management consulting services to healthcare industry clients. All these experiences are being applied by The Sage Group to assist industry participants in these challenging times.
Monte Athos 355-502
Lomas de Chapultepec
11000 México DF
Tel: +52-55 5520-1556
or +52-55 5540-0965
Mobile: +521 55 5408-2424